查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年胃滯留給藥系統市場預測：按類型、劑型、配銷通路和地區分類的全球分析
市場調查報告書
商品編碼
1371994

2030 年胃滯留給藥系統市場預測：按類型、劑型、配銷通路和地區分類的全球分析

Gastro-retentive Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Type, Dosage Form, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球胃滯留給藥系統市場規模為 149 億美元，預測期內年複合成長率為 12.1%，到 2030 年將達到 331 億美元。

「胃滯留藥物遞送」指用於將藥物化合物遞送至胃腸道內目標部位的方法、製劑、製造技術、儲存系統和技術，並決定藥物遞送系統的功效和安全性。應用製造、給藥途徑、位點特異性標靶、代謝和毒性來提高藥物生產。透過胃滯留給藥方法加強黏膜保護可用於預防和控制病理。

根據亞利桑那大學發表的論文，新興國家的幽門螺旋桿菌病菌感染高於已開發國家。在開發中國家% 。

胃藥需求不斷成長

主要製藥公司配合措施改善胃滯留藥物傳輸系統，以及由於生物利用度提高而增加的藥物需求和減少的給藥，推動了市場成長。此外，胃滯留藥物輸送系統在治療各種類型的胃病（包括消化性潰瘍和胃潰瘍）方面的功效已得到證實，而導致胃炎和胃癌的幽門螺旋桿菌病菌感染的患病正在增加。使胃滯留藥物得以使用，並對市場擴張產生了重大影響。

患者接受度下降

由於這些新的給藥技術具有創新性，因此很難被患者接受。此外，傳統的口服劑型可能是優選的，特別是對於吞嚥困難或喜歡較小劑型的患者。此外，確保一致的依從性也很困難，因為它依賴於患者遵循特定的給藥指示。因此，有些患者發現胃滯留藥物輸送系統（GRDDS）的尺寸和特性較不方便，市場可能會大幅下降。

技術進步

胃滯留給藥技術的使用已被證明是控制各種藥物給藥同時提高生物利用度的有效技術。此外，近年來，超越胃排空時間不規則和胃停留時間短等物理挑戰的技術創新導致了受控口服給藥系統的改進。此外，once-GRDDS可以透過延長在上胃腸道的停留時間來提高治療效果和口服生物利用度。因此，這些進步是推動市場規模擴大的驅動力。

與配方相關的風險

在創造能夠始終黏附在胃腸黏膜或漂浮在胃中同時以受控速率釋放藥物的藥物製劑中，需要克服一些挑戰。此外，實現黏度、浮力和控制釋放之間的平衡需要精確的配方方法和徹底的研究。此外，需要確保藥物在胃腸道環境中的穩定性進一步增加了難度。因此，這些困難往往會導致更長的開發時間和更高的價格，從而影響市場成長。

COVID-19 的影響

胃滯留給藥系統 (GRDDS) 市場受到了 COVID-19 爆發的負面影響。當醫療保健系統專注於對抗病毒時，基於 GRDDS 的藥物開發的臨床試驗和研究被推遲。此外，進入醫療保健設施受到限制，影響了臨床試驗的患者招募和創新藥物輸送方法的引入。此外，經濟限制和供應鏈中斷阻礙了 GRDDS 產品的生產和分銷。因此，由於疫情導致醫療保健系統的財政負擔日益增加，《新藥交付法案》的預算受到影響，逐漸阻礙了市場的成長。

浮動藥物傳輸系統（FDDS）領域預計將在預測期內達到最大的領域

預計浮動給藥系統領域將佔最大佔有率。這些藥物製劑會長時間懸浮在胃中。此外，這些方法允許藥物在胃液中漂浮的同時逐漸釋放，改善藥物吸收並延長治療效果。漂浮藥物輸送系統（FDDS）可以減少副作用、減少給藥頻率並增加藥物吸收。此外，它對吸收窗較小的藥物特別有效，用於治療多種胃腸道疾病。因此，FDDS作為一種最先進的改善藥物傳遞的方法，可以提高患者的依從性並確保胃腸滯留藥物的治療效果，從而擴大市場規模。

預計微球細分市場在預測期內年複合成長率最高

由於在藥物配方中使用小球形顆粒來改善藥物在胃腸道的吸收，因此預計微球細分市場在預測期內將出現最高的年複合成長率。此外，這些微球可以含有控制釋放的藥物，並且通常由生物相容性材料製成。這些提供了消費後的好處，例如更長的給藥、更少的給藥和更少的副作用。使用微球的GRDDS已用於治療各種胃腸道疾病，提高了患者的依從性和治療效果。因此，本節提出了獨特的藥理學策略，以增強消化器官系統藥物吸收和治療效果，從而顯著推動市場。

比最大的地區

由於其優異的藥物吸收和患者依從性，亞太地區在預測期內佔據了最大的市場佔有率。此外，亞太地區還在醫學研究和基礎設施開發上投入資金，這正在推動創新和市場成長。法規變化和慢性病的增加進一步加速了 GRDDS 的採用。因此，GRDDS 行業的藥房、研究人員和醫療保健專業人員在該地區有很多機會。

複合年複合成長率最高的地區：

歐洲在 GRDDS 技術的進步中發揮著重要作用，預計在預測期內將表現出最高的年複合成長率，因為它同時注重創新和優質醫療保健。此外，該地區高齡化和胃腸道疾病的高患病需要更好的給藥方法。此外，歐洲醫療保健系統正在鼓勵 GRDDS 的開發和部署，以改善治療結果、患者依從性和生活品質。因此，嚴格的法規標準確保了產品安全和充滿活力的市場。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球胃滯留給藥系統市場：依類型

  • 可擴展的藥物傳輸系統
  • 黏合藥物傳輸系統
  • 漂浮給藥系統 (FDDS)
  • 高密度系統
  • 其他類型

第6章 全球胃滯留給藥系統市場：按劑型

  • 微球
  • 藥片
  • 膠囊
  • 其他劑型

第7章 全球胃滯留給藥系統市場：按配銷通路

  • 網路藥房
  • 醫院藥房
  • 零售藥房
  • 其他配銷通路

第8章 全球胃滯留給藥系統市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Ranbaxy
  • GlaxoSmithKline
  • Competition Deep Dive
  • Depomed
  • Pharmacia
  • Alcon, Inc.
  • Lupin
  • Galanix
  • Sun Pharma
  • F. Hoffmann La Roche
Product Code: SMRC24050

According to Stratistics MRC, the Global Gastro-retentive Drug Delivery Systems Market is accounted for $14.9 billion in 2023 and is expected to reach $33.1 billion by 2030 growing at a CAGR of 12.1% during the forecast period. The term "gastro-retentive drug delivery" refers to methods, formulations, production techniques, storage systems, and technologies used to deliver pharmaceutical compounds to the target location in the gastro-intestinal tract, to enhance the effectiveness and safety of a drug delivery system, principles relating to drug manufacturing, route of administration, site-specific targeting, metabolism, and toxicity are applied. The enhancement of mucosal protection by the gastro-retentive drug delivery method can be used to prevent and control the condition.

According to the article published by the University of Arizona, H.pylori infection is higher in developing countries than the developed countries. The incidence of new infections in developing countries is 3 to 10% of the population compared to 0.5% in developed economies.

Market Dynamics:

Driver:

Rising demand for gastro-retentive drugs

The market's growth has been accelerated by large pharmaceutical companies' efforts to improve gastro-retentive drug delivery systems, together with dose reductions due to improved bioavailability and an increase in the demand for drugs. Additionally, the market is greatly influenced by the well-established effectiveness of gastro-retentive drug delivery systems in treating various kinds of stomach disorders, including peptic ulcer and gastric ulcer, as well as an increase in the prevalence of H.pylori infection, which can lead to gastritis and gastric cancer which enabled the use of gastro-retentive drugs resulting in market expansion.

Restraint:

Decrease in Patient acceptance

The innovative nature of these new medicine delivery techniques may make them difficult for patients to accept. Additionally, patients may prefer traditional oral dosage forms especially for individuals who have difficulty swallowing or who prefer smaller-sized dosage forms. Moreover, ensuring consistent compliance is also challenging, as it relies on patients following specific administration instructions. Thus, some patients may find the size or characteristics of Gastro-retentive Drug Delivery Systems (GRDDS) less convenient by which the market gets significantly retrain.

Opportunity:

Technological advancements

The use of gastro-retentive drug delivery technology has proven to be an effective technique to control the dosage of a variety of pharmaceuticals while increasing bioavailability. Moreover, technology innovations that go beyond physical challenges like erratic stomach emptying timings and brief gastric residency times have led to improvements in controlled oral medicine administration systems in recent years. Additionally, once-GRDDS can improve therapeutic effectiveness and oral bioavailability by prolonging their duration in the upper GI tract. Hence, these advancements drive the market size.

Threat:

Risks associated while formulating

There are challenging obstacles to overcome when creating pharmacological formulations that can consistently stick to the gastrointestinal mucosa or float in the stomach while releasing the drug at a controlled rate. Moreover, it takes exact formulation methods and in-depth research to achieve this balance of adhesion, buoyancy, and controlled release. Additionally, the difficulty is increased further by the need to ensure the drug's stability in the gastrointestinal environment. Therefore, these difficulties frequently lead to longer development times and higher prices, which have an effect on market growth.

COVID-19 Impact

The market for gastro-retentive drug delivery systems (GRDDS) has been negatively impacted by the COVID-19 epidemic. Clinical trials and research for the development of GRDDS-based drugs were delayed while healthcare systems concentrated on fighting the virus. Additionally, access to medical facilities became restricted, which had an impact on the recruitment of patients for clinical trials and the uptake of innovative drug delivery methods. Moreover, economical limitations and supply chain interruptions have hampered the manufacture and distribution of GRDDS goods. Therefore, budgets for novel drug delivery methods were impacted as a result of the pandemic's increasing financial load on healthcare systems which gradually hampered the market growth.

The floating drug delivery system (FDDS) segment is expected to be the largest during the forecast period

The floating drug delivery system segment is estimated to hold the largest share. These are drug formulations that remain buoyant in the stomach for an extended period. Additionally, these methods allow medications to release gradually while floating on the gastric fluid, improving drug absorption and extending therapeutic benefits. Floating drug delivery system (FDDS) can reduce side effects, decrease dosage frequency, and increase drug absorption. Furthermore, they are particularly helpful for medications with small absorption windows and are used in the treatment of a variety of gastrointestinal ailments. Therefore, a cutting-edge method for improving medication delivery, FDDS ensures higher patient compliance and therapeutic effectiveness in gastro-retentive medicines thereby increasing the market expansion.

The microspheres segment is expected to have the highest CAGR during the forecast period

The microspheres segment is anticipated to have highest CAGR during the forecast period due to the use of small, spherical particles in medicine formulations to improve absorption of the medicament in the gastrointestinal tract. Additionally, these microspheres can contain medications for controlled release and are typically made of biocompatible substances. They provide advantages after consumption, including longer drug administration, decreased dosage frequency, and reduced side effects. GRDDS with microspheres is used to treat a variety of gastrointestinal illnesses, enhancing patient compliance and therapeutic results. Hence, this section shows an original pharmacological strategy for enhancing gastrointestinal system drug absorption and therapeutic efficacy by significantly driving the market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to due to their better drug absorption and patient compliance. Additionally, the Asia-Pacific region is spending money on medical research and infrastructure, which encourages innovation and market growth. Adoption of GRDDS is further fuelled by regulatory changes and the rise in chronic diseases. Therefore, pharmacies, researchers, and healthcare practitioners in the GRDDS industry have a lot of opportunities in this region.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a major role in the advancement of GRDDS technology, placing a strong emphasis on both innovation and high-quality healthcare. Additionally, there is a need for better drug delivery methods due to the aging population in the area and the high prevalence of gastrointestinal illnesses. Moreover, in order to improve treatment outcomes, patient compliance, and quality of life, European healthcare systems encourage the development and deployment of GRDDS. Hence, stringent regulatory standards ensure product safety, making it a thriving market.

Key players in the market:

Some of the key players in the Gastro-retentive Drug Delivery Systems Market include: Ranbaxy, GlaxoSmithKline, Competition Deep Dive, Depomed, Pharmacia, Alcon, Inc., Lupin, Galanix, Sun Pharma and F. Hoffmann La Roche.

Key Developments:

In October 2023, Sun Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for deuruxolitinib, an investigational oral selective inhibitor of Janus kinases, for the treatment of adults with moderate to severe alopecia areata.

In March 2023, Sun Pharmaceutical Industries Limited announced the successful completion of its acquisition of Concert Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company that is developing deuruxolitinib, a novel, deuterated, oral JAK1/2 inhibitor, for the potential treatment of adult patients with moderate to severe alopecia area.

Types Covered:

  • Expandable Drug Delivery System
  • Bioadhesive Drug Delivery System
  • Floating Drug Delivery System
  • High Density System
  • Other Types

Dosage Forms Covered:

  • Microspheres
  • Tablets
  • Capsule
  • Other Dosage Forms

Distribution Channels Covered:

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gastro-retentive Drug Delivery Systems Market, By Type

  • 5.1 Introduction
  • 5.2 Expandable Drug Delivery System
  • 5.3 Bioadhesive Drug Delivery System
  • 5.4 Floating Drug Delivery System (FDDS)
  • 5.5 High Density System
  • 5.6 Other Types

6 Global Gastro-retentive Drug Delivery Systems Market, By Dosage Form

  • 6.1 Introduction
  • 6.2 Microspheres
  • 6.3 Tablets
  • 6.4 Capsule
  • 6.5 Other Dosage Forms

7 Global Gastro-retentive Drug Delivery Systems Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Pharmacies
  • 7.3 Hospital Pharmacies
  • 7.4 Retail Pharmacies
  • 7.5 Other Distribution Channels

8 Global Gastro-retentive Drug Delivery Systems Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Ranbaxy
  • 10.2 GlaxoSmithKline
  • 10.3 Competition Deep Dive
  • 10.4 Depomed
  • 10.5 Pharmacia
  • 10.6 Alcon, Inc.
  • 10.7 Lupin
  • 10.8 Galanix
  • 10.9 Sun Pharma
  • 10.10 F. Hoffmann La Roche

List of Tables

  • Table 1 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 4 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 5 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 6 Global Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 7 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 9 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 10 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 11 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 12 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 13 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 14 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 15 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 16 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 17 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 18 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 20 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 21 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 22 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 23 North America Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 24 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 25 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 26 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 27 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 28 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 29 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 30 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 31 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 32 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 33 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 34 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 35 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 37 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 38 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 39 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 40 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 41 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 42 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 43 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 44 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 45 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 46 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 47 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 48 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 49 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 50 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 51 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 52 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 55 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 56 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 57 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 58 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 59 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 60 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 61 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 62 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 63 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 64 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 65 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 66 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 67 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 68 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 69 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 71 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 72 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 73 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 74 South America Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 75 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 76 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 77 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 78 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 79 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 80 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 81 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 82 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 83 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 84 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 85 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 86 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 89 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 90 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 91 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 92 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 93 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 94 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 95 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 96 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 97 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 98 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 99 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 100 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 101 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 102 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)